Japanese Logistics Stock News

TSE:4519
TSE:4519Pharmaceuticals

Do Chugai Pharmaceutical's (TSE:4519) Stronger EPS Trends Signal a Shift in Its Profit Model?

Chugai Pharmaceutical Co., Ltd. recently reported past half-year results to June 30, 2026, with sales of ¥566,487 million, revenue of ¥663,331 million, and net income of ¥231,749 million, alongside higher basic and diluted earnings per share from continuing operations year over year. The earnings release highlights that profit growth outpaced sales growth, indicating improved earnings efficiency as reflected in the stronger earnings per share figures. We'll now examine how this stronger...
TSE:1928
TSE:1928Consumer Durables

How Investors May Respond To Sekisui House (TSE:1928) Winning Singapore’s Bayshore Transit-Integrated Mega Project

In July 2026, Frasers Property Limited, Frasers Centrepoint Trust, Sunway MCL Limited, Sekisui House and Lum Chang Building Contractors announced their consortium had emerged as the top bidder for Singapore’s Bayshore Drive Government Land Sales site, a large 99-year mixed-use plot integrated with the Bedok South MRT station and a new bus interchange. The bid positions Sekisui House to participate in one of the largest transit-linked mixed-use projects in Singapore’s East Coast, potentially...
TSE:7751
TSE:7751Tech

Canon (TSE:7751) Stock Looks Cheap After EPS And Margin Jump

Canon stock closed at ¥4,494, leaving the 7 day return slightly in the red even as the latest earnings landed. The headline is not the share price move. The headline is that Q2 basic earnings per share came in at ¥143.16, helping lift trailing 12 month earnings per share to ¥396.44 and supporting a P/E of about 11x against peers on roughly double that multiple. Short term traders see a muted tape. Longer term investors see a company that has expanded net profit margins and is still priced as...
TSE:8273
TSE:8273Multiline Retail

Izumi (TSE:8273) Grew First Quarter Profit, Is The Stock Still Undervalued?

Izumi’s Latest Earnings and Why They Matter Now Izumi (TSE:8273) drew investor attention after reporting first quarter results to May 31, 2026, with sales of ¥125,235 million and net income of ¥4,528 million, both above the prior year period. See our latest analysis for Izumi. Since those earnings, Izumi’s 30 day share price return of 7.27% and 90 day share price return of 6.71% point to improving momentum, although the 3 year total shareholder return is down 7.62% and the 5 year total...
TSE:5857
TSE:5857Metals and Mining

Undiscovered Gems in Asia to Watch This July 2026

As global markets navigate through geopolitical tensions and fluctuating oil prices, the Asian market has shown resilience, with indices like China's CSI 300 Index and Japan's Nikkei 225 Index posting gains despite broader regional uncertainties. In this dynamic environment, identifying promising small-cap stocks can be pivotal for investors seeking to capitalize on growth opportunities within Asia's evolving economic landscape.
TSE:7460
TSE:7460Retail Distributors

Asian Dividend Stocks To Enhance Your Investment Portfolio

Amidst global economic uncertainties and fluctuating oil prices, Asian markets have shown resilience with notable advancements in key indices, such as Japan's Nikkei 225 and China's CSI 300. In this dynamic environment, dividend stocks can offer a stable income stream, making them an attractive option for investors seeking to enhance their portfolios through consistent returns.
TSE:8424
TSE:8424Diversified Financial

Fuyo General Lease (TSE:8424) Files ¥300b Bond Shelf, Is The Stock Fully Valued?

Fuyo General Lease (TSE:8424) has filed a shelf registration for up to ¥300 billion in bonds, a move that puts a sizable funding option in place and draws attention to its capital structure. See our latest analysis for Fuyo General Lease. At a share price of ¥4,520.0, Fuyo General Lease has seen recent momentum build, with a 7 day share price return of 4.03% and a 30 day share price return of 6.73%. Its 1 year total shareholder return of 14.86% and 5 year total shareholder return of 122.61%...
TSE:6098
TSE:6098Professional Services

Is AI‑Led Hiring Innovation Altering The Investment Case For Recruit Holdings (TSE:6098)?

In recent months, Recruit Holdings has drawn attention as analysts’ cash flow models and earnings multiples suggest its shares may be trading below intrinsic value, even as some broader valuation checks remain mixed. An interesting angle is how the company’s push into AI-powered and data-centric hiring solutions is reshaping expectations for its long-term role in global talent matching, despite current softness in labor demand and slower uptake of platforms like Indeed PLUS. We’ll now...
TSE:3626
TSE:3626IT

Is TISI’s Back‑Office Spin Into a Subsidiary Refining Its Investment Story (TSE:3626)?

TISI Inc. previously convened a board meeting on July 24, 2026, to consider having a wholly owned subsidiary succeed certain back-office operations via an absorption-type company split effective October 1, 2026. This potential shift of back-office functions into a subsidiary could alter TISI’s operational structure, with implications for efficiency, cost visibility, and management focus. Next, we will examine how this planned absorption-type company split of back-office operations may...
TSE:8316
TSE:8316Banks

Sumitomo Mitsui Financial Group (TSE:8316) Extends Its Rally, Is The Premium Already Too Rich?

Recent share performance has put Sumitomo Mitsui Financial Group (TSE:8316) on many investors’ radar, with the stock up around 12% over the past month and about 33% in the past 3 months. See our latest analysis for Sumitomo Mitsui Financial Group. At a share price of ¥7,161, Sumitomo Mitsui Financial Group has posted a 12.05% 1 month share price return and a 1 year total shareholder return of 85.91%, alongside a multi year total shareholder return that is several times the initial investment...
TSE:4502
TSE:4502Pharmaceuticals

Can Takeda Pharmaceutical (TSE:4502) Trade At A Discount On New Phase 3 Psoriasis Data?

Takeda Pharmaceutical (TSE:4502) has drawn fresh attention after releasing new Phase 3 data for its oral TYK2 inhibitor zasocitinib in adults with moderate to severe plaque psoriasis, highlighting meaningful skin clearance across difficult areas. See our latest analysis for Takeda Pharmaceutical. Together with the zasocitinib update and the recent plasma collaboration in Indonesia, Takeda Pharmaceutical’s 11.03% 1 month share price return and 35.86% 1 year total shareholder return suggest...
TSE:6532
TSE:6532Professional Services

Baycurrent (TSE:6532) Earnings Strength Raises The Question Of Whether The Stock Is Fully Valued

Why Baycurrent’s Latest Earnings Matter for Investors Baycurrent (TSE:6532) has drawn fresh attention after reporting first quarter earnings, with sales of ¥44,576 million, net income of ¥10,733 million, and basic earnings per share of ¥70.99 from continuing operations. These figures compare with sales of ¥34,307 million, net income of ¥9,016 million, and basic earnings per share of ¥59.32 in the same quarter a year earlier, giving investors updated context on Baycurrent’s consulting focused...
TSE:6946
TSE:6946Electronic

Nomura Micro Science Among 3 Asian Stocks Priced Below Estimated Value

Amidst a backdrop of geopolitical tensions and fluctuating oil prices, Asian markets have shown resilience, with indices like the Nikkei 225 and CSI 300 making notable gains. In this environment, identifying undervalued stocks can be crucial for investors looking to capitalize on market inefficiencies; Nomura Micro Science is among those currently priced below their estimated value.
TSE:8370
TSE:8370Banks

CIMC Enric Holdings And 2 Other Asian Dividend Stocks To Consider

As Asian markets navigate the complexities of geopolitical tensions and fluctuating oil prices, investors are increasingly focused on finding stable returns amidst volatility. In this environment, dividend stocks like CIMC Enric Holdings offer a potential avenue for income generation, providing a buffer against market uncertainties while contributing to portfolio stability.